Ipamorelin is a synthetic pentapeptide and a highly selective growth hormone secretagogue (GHS)
Then, our independent Pharmacy & Therapeutics (P&T) Committee reviews clinical and safety information, and provides recommendations for formulary inclusion
In February 2025 , Mankind Pharma announced that it is developing an oral anti-obesity drug, which could become the first small-molecule treatment for obesity globally if successful
Liu H, Pan M, Liu M, Zeng L, Li Y, Huang Z
Yue Geng, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers